Study to Evaluate the Efficacy and Safety of | Clinical Research Studies Listing

Study to Evaluate the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

Recruiting

18 years - 80 years

All

Phase 2

10 participants needed

1 Location

Brief description of study

The research study is being conducted to see how safe and effective an investigational drug called evinacumab is in people who have severe hypertriglyceridemia (elevated levels of fat in the blood).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Pancreatitis
Age: 18 years - 80 years
Gender: All

Male and Females, Age 18-80, Hypertriglyceridemia

Updated on 04 Aug 2024. Study ID: 849561

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Evaluate the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

Brief description of study

Eligibility of study

Find a site

Interested in the study